Xerox Phaser 6200 Guide De Support page 25

Fiches de sécurité du matériel (en anglais uniquement)
Additional Information: The results obtained from a Xerox sponsored Chronic Toner Inhalation Study
3
demonstrated no lung changes in rats for the lowest (1 mg/m ) exposure level (ie., the level most relevant to
potential human exposure). A very slight degree of fibrosis was noted in 25% of the animals at the middle
3 3
(4 mg/m ) exposure level, while a slight degree of fibrosis was noted in all the animals at the highest (16 mg/m )
exposure level. The findings are attributed to "lung overloading", a generic response to excessive amounts of any
dust retained in the lungs for a prolonged period. This study was conducted using a special test toner to comply with
EPA testing protocol. The test toner was ten times more respirable than commercially available Xerox toner and
would not be functionally suitable for Xerox equipment.
SECTION 12 - ECOLOGICAL INFORMATION
Not available
SECTION 13 - DISPOSAL CONSIDERATIONS
These materials are not RCRA hazardous wastes as specified in 40 CFR 261. State and local waste disposal
requirements, however, may be more restrictive. Dispose in accordance with all federal, state, and local regulations.
Incinerate only in a closed container.
SECTION 14 - TRANSPORT INFORMATION
DOT: Not regulated.
SECTION 15 - REGULATORY INFORMATION
TSCA: All components of these toners have been manufactured in compliance with TSCA.
CANADIAN WHMIS: These toners are not regulated as controlled products under the Workplace Hazardous
Material Information System (WHMIS).
SECTION 16 - OTHER INFORMATION
NFPA 704: Health-0, Fire-3, Reactivity-0 (All colors)
Original preparation date: 1/15/02
Xerox Corporation
Office Printing Business
Environmental, Health & Safety
P.O. Box 1000
Mail Stop 60-512
Wilsonville, Oregon 97070
Safety Information: 800-828-6571
Health Emergency: 716-422-2177
Transportation Emergency (Chemtrec): 800-424-9300
Imprimante couleur laser Phaser® 6200 22